Houston airports deploy disinfecting robots in their terminals

now boarding: automation

Six Breezy One robots have landed in Houston's airports. Photo via buildwithrobots.com

What stands four feet tall, measures 22 inches wide, and weighs about 265 pounds? One of the six robots that disinfect George Bush Intercontinental/Houston Airport and William P. Hobby Airport.

Last year, the Houston Airport System spent close to $1 million for six Breezy One robots made by Albuquerque, New Mexico-based Build With Robots. The robots, each costing $160,000, now help the airports’ human crews keep the two airports sanitized.

George Bush Intercontinental has four of the robots, and Hobby has two.

“Breezy One is an autonomous disinfecting robot. It moves on its own and disinfects any route that someone chooses at the push of a button. It disperses a disinfectant fog which reaches all surfaces, penetrates fabrics, and even disinfects the air,” according to Build With Robots.

The robot disinfects germy surfaces such as tables, chairs, doorknobs, and keyboards. A Breezy One robot can decontaminate more than 150,000 square feet of space in one hour with a patented, environmentally safe disinfectant, purportedly eliminating 99.9999 percent of viruses and bacteria. New Mexico’s Sandia National Laboratories developed the disinfectant.

Build With Robots, founded in 2017, launched Breezy One in 2020 at the Albuquerque International Sunport. The company developed the technology in conjunction with the City of Albuquerque’s Aviation Department. In January, Build With Robots announced it raised $5 million in funding. That was preceded by a seed round of about $1 million.

Before the disinfectant-filled robots go about their work, members of the Build With Robots team map the buildings where they’ll operate autonomously. The team members then load the maps into the robots. The robots follow commands given by a facility’s custodial team.

Traci Rutoski, manager of custodial services at Hobby, says Build With Robots “is providing us with the best tools to keep our passengers, employees, and stakeholders safe.”

Sam Rea, terminal manager at George Bush Intercontinental, says the Breezy One robots have enabled the airport to step up cleanliness in the COVID-19 era.

“With the onset of the pandemic, we needed to explore new and innovative solutions so that when people come through the airports, whether for work or travel, they feel safe and secure,” Rhea says in a news release.

Augusto Bernal, a spokesman for the Houston Airport System, says that while the disinfecting robots have been effective, there are no plans to add more of them.

Aside from the Houston Airport System and the Albuquerque airport, customers of Build With Robots include HVAC manufacturer Goodwin’s 4.2-million-square-foot operation at Daikin Texas Technology Park in Waller, Mount Vernon ISD in East Texas, the University of New Mexico in Albuquerque and Albuquerque’s Electric Playhouse amusement center. The robots, which can be purchased or leased, are designed to sanitize airports, arenas, stadiums, school buildings, and other heavily trafficked places.

Goodwin has installed one robot in Waller.

“This robot’s going to be able to clean 200,000 square feet of office and conference rooms in two, maybe two-and-a-half hours,” Charlie Strange, facilities manager at Goodwin’s Waller operation, told The Verge last November. “It would take my team all night long to do that — wiping down every surface by hand.”

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."